Cardiometabolic drugs are purposefully used for a vast composition of metabolic dysfunction, disorders include impaired glucose tolerance, insulin resistance, hypertension, dyslipidemia, and central adiposity.

Market Analysis and Insights: Global Cardiometabolic Drug Market

The global Cardiometabolic Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Cardiometabolic Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cardiometabolic Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cardiometabolic Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cardiometabolic Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cardiometabolic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cardiometabolic Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cardiometabolic Drug Market Report

Report Metric	Details
Report Name	Cardiometabolic Drug Market
CAGR	5%
Segment by Type	Impaired Glucose Tolerance Drug Insulin Resistance Drug Hypertension Drug Dyslipidemia Drug Central Adiposity Drug
Segment by Application	Hospital Pharmacies Online Pharnacies Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gilead Sciences, AbbVie, Sanofi, InovoBiologic, Carmel Biosciences, Genfit, Kochi Prefecture, Besins Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cardiometabolic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiometabolic Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiometabolic Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Cardiometabolic Drug Market report?

Ans: The main players in the Cardiometabolic Drug Market are Gilead Sciences, AbbVie, Sanofi, InovoBiologic, Carmel Biosciences, Genfit, Kochi Prefecture, Besins Healthcare

What are the Application segmentation covered in the Cardiometabolic Drug Market report?

Ans: The Applications covered in the Cardiometabolic Drug Market report are Hospital Pharmacies, Online Pharnacies, Retail Pharmacies

What are the Type segmentation covered in the Cardiometabolic Drug Market report?

Ans: The Types covered in the Cardiometabolic Drug Market report are Impaired Glucose Tolerance Drug, Insulin Resistance Drug, Hypertension Drug, Dyslipidemia Drug, Central Adiposity Drug

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cardiometabolic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Impaired Glucose Tolerance Drug

1.2.3 Insulin Resistance Drug

1.2.4 Hypertension Drug

1.2.5 Dyslipidemia Drug

1.2.6 Central Adiposity Drug

1.3 Market by Application

1.3.1 Global Cardiometabolic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Online Pharnacies

1.3.4 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cardiometabolic Drug Market Perspective (2019-2030)

2.2 Global Cardiometabolic Drug Growth Trends by Region

2.2.1 Cardiometabolic Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cardiometabolic Drug Historic Market Size by Region (2019-2024)

2.2.3 Cardiometabolic Drug Forecasted Market Size by Region (2025-2030)

2.3 Cardiometabolic Drug Market Dynamics

2.3.1 Cardiometabolic Drug Industry Trends

2.3.2 Cardiometabolic Drug Market Drivers

2.3.3 Cardiometabolic Drug Market Challenges

2.3.4 Cardiometabolic Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cardiometabolic Drug by Players

3.1.1 Global Cardiometabolic Drug Revenue by Players (2019-2024)

3.1.2 Global Cardiometabolic Drug Revenue Market Share by Players (2019-2024)

3.2 Global Cardiometabolic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cardiometabolic Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cardiometabolic Drug Market Concentration Ratio

3.4.1 Global Cardiometabolic Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cardiometabolic Drug Revenue in 2023

3.5 Global Key Players of Cardiometabolic Drug Head office and Area Served

3.6 Global Key Players of Cardiometabolic Drug, Product and Application

3.7 Global Key Players of Cardiometabolic Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiometabolic Drug Breakdown Data by Type

4.1 Global Cardiometabolic Drug Historic Market Size by Type (2019-2024)

4.2 Global Cardiometabolic Drug Forecasted Market Size by Type (2025-2030)

5 Cardiometabolic Drug Breakdown Data by Application

5.1 Global Cardiometabolic Drug Historic Market Size by Application (2019-2024)

5.2 Global Cardiometabolic Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cardiometabolic Drug Market Size (2019-2030)

6.2 North America Cardiometabolic Drug Market Size by Type

6.2.1 North America Cardiometabolic Drug Market Size by Type (2019-2024)

6.2.2 North America Cardiometabolic Drug Market Size by Type (2025-2030)

6.2.3 North America Cardiometabolic Drug Market Share by Type (2019-2030)

6.3 North America Cardiometabolic Drug Market Size by Application

6.3.1 North America Cardiometabolic Drug Market Size by Application (2019-2024)

6.3.2 North America Cardiometabolic Drug Market Size by Application (2025-2030)

6.3.3 North America Cardiometabolic Drug Market Share by Application (2019-2030)

6.4 North America Cardiometabolic Drug Market Size by Country

6.4.1 North America Cardiometabolic Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cardiometabolic Drug Market Size by Country (2019-2024)

6.4.3 North America Cardiometabolic Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cardiometabolic Drug Market Size (2019-2030)

7.2 Europe Cardiometabolic Drug Market Size by Type

7.2.1 Europe Cardiometabolic Drug Market Size by Type (2019-2024)

7.2.2 Europe Cardiometabolic Drug Market Size by Type (2025-2030)

7.2.3 Europe Cardiometabolic Drug Market Share by Type (2019-2030)

7.3 Europe Cardiometabolic Drug Market Size by Application

7.3.1 Europe Cardiometabolic Drug Market Size by Application (2019-2024)

7.3.2 Europe Cardiometabolic Drug Market Size by Application (2025-2030)

7.3.3 Europe Cardiometabolic Drug Market Share by Application (2019-2030)

7.4 Europe Cardiometabolic Drug Market Size by Country

7.4.1 Europe Cardiometabolic Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cardiometabolic Drug Market Size by Country (2019-2024)

7.4.3 Europe Cardiometabolic Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cardiometabolic Drug Market Size (2019-2030)

8.2 China Cardiometabolic Drug Market Size by Type

8.2.1 China Cardiometabolic Drug Market Size by Type (2019-2024)

8.2.2 China Cardiometabolic Drug Market Size by Type (2025-2030)

8.2.3 China Cardiometabolic Drug Market Share by Type (2019-2030)

8.3 China Cardiometabolic Drug Market Size by Application

8.3.1 China Cardiometabolic Drug Market Size by Application (2019-2024)

8.3.2 China Cardiometabolic Drug Market Size by Application (2025-2030)

8.3.3 China Cardiometabolic Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cardiometabolic Drug Market Size (2019-2030)

9.2 Asia Cardiometabolic Drug Market Size by Type

9.2.1 Asia Cardiometabolic Drug Market Size by Type (2019-2024)

9.2.2 Asia Cardiometabolic Drug Market Size by Type (2025-2030)

9.2.3 Asia Cardiometabolic Drug Market Share by Type (2019-2030)

9.3 Asia Cardiometabolic Drug Market Size by Application

9.3.1 Asia Cardiometabolic Drug Market Size by Application (2019-2024)

9.3.2 Asia Cardiometabolic Drug Market Size by Application (2025-2030)

9.3.3 Asia Cardiometabolic Drug Market Share by Application (2019-2030)

9.4 Asia Cardiometabolic Drug Market Size by Region

9.4.1 Asia Cardiometabolic Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cardiometabolic Drug Market Size by Region (2019-2024)

9.4.3 Asia Cardiometabolic Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cardiometabolic Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cardiometabolic Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Gilead Sciences

11.1.1 Gilead Sciences Company Details

11.1.2 Gilead Sciences Business Overview

11.1.3 Gilead Sciences Cardiometabolic Drug Introduction

11.1.4 Gilead Sciences Revenue in Cardiometabolic Drug Business (2019-2024)

11.1.5 Gilead Sciences Recent Developments

11.2 AbbVie

11.2.1 AbbVie Company Details

11.2.2 AbbVie Business Overview

11.2.3 AbbVie Cardiometabolic Drug Introduction

11.2.4 AbbVie Revenue in Cardiometabolic Drug Business (2019-2024)

11.2.5 AbbVie Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Cardiometabolic Drug Introduction

11.3.4 Sanofi Revenue in Cardiometabolic Drug Business (2019-2024)

11.3.5 Sanofi Recent Developments

11.4 InovoBiologic

11.4.1 InovoBiologic Company Details

11.4.2 InovoBiologic Business Overview

11.4.3 InovoBiologic Cardiometabolic Drug Introduction

11.4.4 InovoBiologic Revenue in Cardiometabolic Drug Business (2019-2024)

11.4.5 InovoBiologic Recent Developments

11.5 Carmel Biosciences

11.5.1 Carmel Biosciences Company Details

11.5.2 Carmel Biosciences Business Overview

11.5.3 Carmel Biosciences Cardiometabolic Drug Introduction

11.5.4 Carmel Biosciences Revenue in Cardiometabolic Drug Business (2019-2024)

11.5.5 Carmel Biosciences Recent Developments

11.6 Genfit

11.6.1 Genfit Company Details

11.6.2 Genfit Business Overview

11.6.3 Genfit Cardiometabolic Drug Introduction

11.6.4 Genfit Revenue in Cardiometabolic Drug Business (2019-2024)

11.6.5 Genfit Recent Developments

11.7 Kochi Prefecture

11.7.1 Kochi Prefecture Company Details

11.7.2 Kochi Prefecture Business Overview

11.7.3 Kochi Prefecture Cardiometabolic Drug Introduction

11.7.4 Kochi Prefecture Revenue in Cardiometabolic Drug Business (2019-2024)

11.7.5 Kochi Prefecture Recent Developments

11.8 Besins Healthcare

11.8.1 Besins Healthcare Company Details

11.8.2 Besins Healthcare Business Overview

11.8.3 Besins Healthcare Cardiometabolic Drug Introduction

11.8.4 Besins Healthcare Revenue in Cardiometabolic Drug Business (2019-2024)

11.8.5 Besins Healthcare Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Cardiometabolic Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Impaired Glucose Tolerance Drug

Table 3. Key Players of Insulin Resistance Drug

Table 4. Key Players of Hypertension Drug

Table 5. Key Players of Dyslipidemia Drug

Table 6. Key Players of Central Adiposity Drug

Table 7. Global Cardiometabolic Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Cardiometabolic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Cardiometabolic Drug Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Cardiometabolic Drug Market Share by Region (2019-2024)

Table 11. Global Cardiometabolic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Cardiometabolic Drug Market Share by Region (2025-2030)

Table 13. Cardiometabolic Drug Market Trends

Table 14. Cardiometabolic Drug Market Drivers

Table 15. Cardiometabolic Drug Market Challenges

Table 16. Cardiometabolic Drug Market Restraints

Table 17. Global Cardiometabolic Drug Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Cardiometabolic Drug Revenue Share by Players (2019-2024)

Table 19. Global Top Cardiometabolic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiometabolic Drug as of 2023)

Table 20. Global Cardiometabolic Drug Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Cardiometabolic Drug Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Cardiometabolic Drug, Headquarters and Area Served

Table 23. Global Key Players of Cardiometabolic Drug, Product and Application

Table 24. Global Key Players of Cardiometabolic Drug, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cardiometabolic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Cardiometabolic Drug Revenue Market Share by Type (2019-2024)

Table 28. Global Cardiometabolic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Cardiometabolic Drug Revenue Market Share by Type (2025-2030)

Table 30. Global Cardiometabolic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Cardiometabolic Drug Revenue Share by Application (2019-2024)

Table 32. Global Cardiometabolic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Cardiometabolic Drug Revenue Share by Application (2025-2030)

Table 34. North America Cardiometabolic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Cardiometabolic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Cardiometabolic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Cardiometabolic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Cardiometabolic Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Cardiometabolic Drug Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Cardiometabolic Drug Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Cardiometabolic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Cardiometabolic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Cardiometabolic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Cardiometabolic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Cardiometabolic Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Cardiometabolic Drug Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Cardiometabolic Drug Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Cardiometabolic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Cardiometabolic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Cardiometabolic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Cardiometabolic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Cardiometabolic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Cardiometabolic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Cardiometabolic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Cardiometabolic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Cardiometabolic Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Cardiometabolic Drug Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Cardiometabolic Drug Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Cardiometabolic Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size by Country (2025-2030) & (US$ Million)

Table 66. Gilead Sciences Company Details

Table 67. Gilead Sciences Business Overview

Table 68. Gilead Sciences Cardiometabolic Drug Product

Table 69. Gilead Sciences Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 70. Gilead Sciences Recent Developments

Table 71. AbbVie Company Details

Table 72. AbbVie Business Overview

Table 73. AbbVie Cardiometabolic Drug Product

Table 74. AbbVie Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 75. AbbVie Recent Developments

Table 76. Sanofi Company Details

Table 77. Sanofi Business Overview

Table 78. Sanofi Cardiometabolic Drug Product

Table 79. Sanofi Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 80. Sanofi Recent Developments

Table 81. InovoBiologic Company Details

Table 82. InovoBiologic Business Overview

Table 83. InovoBiologic Cardiometabolic Drug Product

Table 84. InovoBiologic Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 85. InovoBiologic Recent Developments

Table 86. Carmel Biosciences Company Details

Table 87. Carmel Biosciences Business Overview

Table 88. Carmel Biosciences Cardiometabolic Drug Product

Table 89. Carmel Biosciences Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 90. Carmel Biosciences Recent Developments

Table 91. Genfit Company Details

Table 92. Genfit Business Overview

Table 93. Genfit Cardiometabolic Drug Product

Table 94. Genfit Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 95. Genfit Recent Developments

Table 96. Kochi Prefecture Company Details

Table 97. Kochi Prefecture Business Overview

Table 98. Kochi Prefecture Cardiometabolic Drug Product

Table 99. Kochi Prefecture Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 100. Kochi Prefecture Recent Developments

Table 101. Besins Healthcare Company Details

Table 102. Besins Healthcare Business Overview

Table 103. Besins Healthcare Cardiometabolic Drug Product

Table 104. Besins Healthcare Revenue in Cardiometabolic Drug Business (2019-2024) & (US$ Million)

Table 105. Besins Healthcare Recent Developments

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cardiometabolic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cardiometabolic Drug Market Share by Type: 2023 VS 2030

Figure 3. Impaired Glucose Tolerance Drug Features

Figure 4. Insulin Resistance Drug Features

Figure 5. Hypertension Drug Features

Figure 6. Dyslipidemia Drug Features

Figure 7. Central Adiposity Drug Features

Figure 8. Global Cardiometabolic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Cardiometabolic Drug Market Share by Application: 2023 VS 2030

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Online Pharnacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Cardiometabolic Drug Report Years Considered

Figure 14. Global Cardiometabolic Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Cardiometabolic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Cardiometabolic Drug Market Share by Region: 2023 VS 2030

Figure 17. Global Cardiometabolic Drug Market Share by Players in 2023

Figure 18. Global Top Cardiometabolic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiometabolic Drug as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Cardiometabolic Drug Revenue in 2023

Figure 20. North America Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Cardiometabolic Drug Market Share by Type (2019-2030)

Figure 22. North America Cardiometabolic Drug Market Share by Application (2019-2030)

Figure 23. North America Cardiometabolic Drug Market Share by Country (2019-2030)

Figure 24. United States Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Cardiometabolic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Cardiometabolic Drug Market Share by Type (2019-2030)

Figure 28. Europe Cardiometabolic Drug Market Share by Application (2019-2030)

Figure 29. Europe Cardiometabolic Drug Market Share by Country (2019-2030)

Figure 30. Germany Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Cardiometabolic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Cardiometabolic Drug Market Share by Type (2019-2030)

Figure 38. China Cardiometabolic Drug Market Share by Application (2019-2030)

Figure 39. Asia Cardiometabolic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Cardiometabolic Drug Market Share by Type (2019-2030)

Figure 41. Asia Cardiometabolic Drug Market Share by Application (2019-2030)

Figure 42. Asia Cardiometabolic Drug Market Share by Region (2019-2030)

Figure 43. Japan Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Cardiometabolic Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Cardiometabolic Drug Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Cardiometabolic Drug Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Cardiometabolic Drug Market Share by Country (2019-2030)

Figure 53. Brazil Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Cardiometabolic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Gilead Sciences Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 60. AbbVie Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 61. Sanofi Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 62. InovoBiologic Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 63. Carmel Biosciences Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 64. Genfit Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 65. Kochi Prefecture Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 66. Besins Healthcare Revenue Growth Rate in Cardiometabolic Drug Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cardiometabolic Diseases Market Research Report 2024

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

Global Cardiomyopathy Medication Market Insights Forecast to 2030

Global Hypoglycemic Drugs Market Insights Forecast to 2030

Global Atherosclerosis Drugs Market Insights Forecast to 2030

Global Diabetes Care Drugs Market Insights Forecast to 2030

Global Lipid regulating Drugs Market Insights Forecast to 2030

Global Blood Pressure Disorders Drug Market Insights Forecast to 2030

Global Orthostatic Hypotension Drugs Market Insights Forecast to 2030

Global Weight Loss Therapeutics Market Insights Forecast to 2030

Global Atherosclerosis Drug Market Insights Forecast to 2030

Global Diabetes Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030

Global ADHD Medications Market Insights Forecast to 2030

Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030

Metabolic Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Antidepressants Drugs Market Insights Forecast to 2030

Global Anti Parkinson Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Liposomal Doxorubicin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39C8806

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Dermatology OTC Medications Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19E9062

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Epinephrine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-7T781

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Atropine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-18119

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions